Skip to Content

M945 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint M945 is Blue, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M945

Divalproex Sodium Delayed-Release

Imprint:
M945
Strength:
500 mg
Color:
Blue
Size:
20.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
ferrosoferric oxide
silicon dioxide
copovidone
croscarmellose sodium
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
lactose monohydrate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polydextrose
polyethylene glycol
polysorbate 80
polyvinyl alcohol
propylene glycol
sodium hydroxide
magnesium silicate
titanium dioxide
triacetin
triethyl citrate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0475 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide